14 December 2020

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

14 December 2020 | n=42

  1. Kimura CMS, Nahas CSR, Silva-Filho EV, Ribeiro VL, et al.
    High-risk HPV test in anal smears: can it optimize the screening for anal cancer?
    AIDS 2020.

  2. Hickey MD, Imbert E, Glidden DV, Rosario JBD, et al.
    Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP).
    AIDS 2020.

  3. Mocroft A.
    The relationship between smoking, current CD4, viral load and cancer in persons living with HIV.
    AIDS 2020.

  4. Falasca K, Lanuti P, Ucciferri C, Pieragostino D, et al.
    Circulating extracellular vesicles as new inflammation marker in hiv infection.
    AIDS 2020.

  5. Handoko R, Chan P, Jagodzinski L, Pinyakorn S, et al.
    Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
    AIDS 2020.

  6. Mu W, Sharma M, Heymans R, Ritou E, et al.
    ApoA-I mimetics attenuate macrophage activation in chronic treated HIV.
    AIDS 2020.

  7. Xiang Y, Fujimoto K, Li F, Wang Q, et al.
    Identifying influential neighbors in social networks and venue affiliations among young MSM: A data science approach to predict HIV infection.
    AIDS 2020.

  8. Fiorentino M, Eubanks A, Coulaud PJ, Couderc C, et al.
    Homonegativity, sexual violence and condom use with women in men who have sex with men and women in West Africa (CohMSM).
    AIDS 2020.

  9. Estcourt C, Yeung A, Nandwani R, Goldberg D, et al.
    Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM.
    AIDS 2020.

  10. Behrens N, Love M, Bandlamuri M, Bernhardt D, et al.
    Characterization of HIV-1 Envelope V3 Region Sequences from Virologically Controlled HIV-Infected Older Patients on Long Term Antiretroviral Therapy.
    AIDS Res Hum Retroviruses 2020.

  11. Xie YN, Li SL, Yang RR, Huang J, et al.
    Genetic characteristics of three unique recombinant forms of HIV-1 in Yunnan, China.
    AIDS Res Hum Retroviruses 2020.

  12. Lan Y, Li L, Deng X, Cai X, et al.
    Near full-length genomic characterization of a novel HIV-1 B/C recombinant form identified in Guangdong Province, China.
    AIDS Res Hum Retroviruses 2020.

  13. Zhu G, Han J, Li H, Liu Y, et al.
    Near full-length Genomic Characterization of 16 HIV-1 CRF01_AE Primary Isolates from Guangxi, China.
    AIDS Res Hum Retroviruses 2020.

  14. Peng X, Xu Y, Wu N.
    Beijing as the hub of CRF07_BC transmission from the intravenous drug users to men who have sex with men in China.
    AIDS Res Hum Retroviruses 2020.

  15. Sno R, Labadie-Bracho MY, Grunberg MG, Adhin MR, et al.
    First Assessment of Acquired HIV-1 Drug Resistance and Mutation Patterns in Suriname.
    AIDS Res Hum Retroviruses 2020.

  16. Baldin G, Ciccullo A, Lombardi F, D'Angelillo A, et al.
    Comparing lamivudine+dolutegravir and bictegravir/emtricitabine/tenofovir alafenamide as switch strategies: preliminary results from clinical practice.
    AIDS Res Hum Retroviruses 2020.

  17. Bercot B, Charreau I, Clotilde R, Delaugerre C, et al.
    High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men who Have Sex with Men. A Sub-Study of the ANRS Ipergay PrEP Trial.
    Clin Infect Dis 2020.

  18. Lv Y, Li G, Hu M, Xu C, et al.
    Anonymous linkage between college students and HIV facilities: systematic evaluation of urine self-collection for HIV testing initiative in China.
    Clin Infect Dis 2020.

  19. Singh D, Switzer WM, Belcher R, Daltry D, et al.
    Identification of an HIV-1 and Neurosyphilis Cluster in Vermont.
    Clin Infect Dis 2020.

  20. Donovan J, Oanh PKN, Dobbs N, Phu NH, et al.
    Optic nerve sheath ultrasound for the detection and monitoring of raised intracranial pressure in tuberculous meningitis.
    Clin Infect Dis 2020.

  21. Kendall EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al.
    The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
    Clin Infect Dis 2020.

  22. Abbasi J.
    Long-acting Cabotegravir Shot Prevents HIV Among Women.
    JAMA 2020;324:2247.

  23. Spring S, O'Bryan J, McMahon J, Woolley I, et al.
    Acceptability of Injectable Antiretroviral Therapy in Australian Travelers With HIV.
    J Acquir Immune Defic Syndr 2021;86:e13-e15.

  24. Fabbiani M, Borghetti A, Squillace N, Colafigli M, et al.
    Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy.
    J Acquir Immune Defic Syndr 2021;86:119-127.

  25. Dunn D, Price H, Vudriko T, Kityo C, et al.
    New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.
    J Acquir Immune Defic Syndr 2021;86:98-103.

  26. Ellsworth GB, Burke LA, Wells MT, Mishra S, et al.
    Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral Treatment.
    J Acquir Immune Defic Syndr 2021;86:73-80.

  27. Onono M, Odwar T, Wahome S, Helova A, et al.
    Behavioral Interventions can Mitigate Adverse Pregnancy Outcomes Among Women Conceiving on ART and Those Initiated on ART During Pregnancy: Findings From the MOTIVATE Trial in Southwestern Kenya.
    J Acquir Immune Defic Syndr 2021;86:46-55.

  28. Schneider JA, Young L, Ramachandran A, Michaels S, et al.
    A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago.
    J Acquir Immune Defic Syndr 2021;86:31-37.

  29. Pahwa S, Deeks S, Zou S, Tomitch N, et al.
    NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research.
    J Acquir Immune Defic Syndr 2021;86:11-18.

  30. Ellis RJ, Iudicello J, Sun-Suslow N, Grelotti D, et al.
    Social isolation is linked to inflammation in aging people with HIV and uninfected individuals.
    J Acquir Immune Defic Syndr 2020.

  31. Abrams EJ, Mofenson LM, Pozniak A, Lockman S, et al.
    Enhanced and timely investigation of ARVs for use in pregnant women.
    J Acquir Immune Defic Syndr 2020.

  32. Simonetti FR, Zhang H, Soroosh GP, Duan J, et al.
    Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo.
    J Clin Invest 2020.

  33. Pillay BA, Fusaro M, Gray PE, Statham AL, et al.
    Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency.
    J Clin Invest 2020.

  34. Lathouwers E, Weinsteiger S, Baugh B, Ghys A, et al.
    Week 96 resistance analyses of the once-daily, Single-tablet Regimen (STR) Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials.
    J Med Virol 2020.

  35. Wan T, Liu X, Su Y, Zou J, et al.
    Biological Differentiation of Traditional Chinese Medicine from Excessive to Deficient Syndromes in AIDS: Comparative MicroRNA Microarray Profiling and Syndrome-Specific Biomarker Identification.
    J Med Virol 2020.

  36. Akiyama H, Jalloh S, Park S, Lei M, et al.
    Expression of HIV-1 Intron-Containing RNA in Microglia Induces Inflammatory Responses.
    J Virol 2020.

  37. Lorenzi JCC, Mendoza P, Cohen YZ, Nogueira L, et al.
    Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates.
    J Virol 2020.

  38. Vezina D, Gong SY, Tolbert WD, Ding S, et al.
    Stabilizing the HIV-1 envelope glycoprotein State 2A conformation.
    J Virol 2020.

  39. Drouin A, Migraine J, Durand MA, Moreau A, et al.
    Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.
    J Virol 2020.

  40. Voysey M, Clemens SAC, Madhi SA, Weckx LY, et al.
    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Lancet 2020.

  41. Mitja O, Corbacho-Monne M, Ubals M, Alemany A, et al.
    A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
    N Engl J Med 2020.

  42. Kaiser J.
    HIV researcher named to lead battered CDC.
    Science 2020;370:1256.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

25 January 2021

18 January 2021

11 January 2021

04 January 2021

28 December 2020


14 December 2020

Multidisciplinary Journal Club

  1. Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, et al.
    Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.

  2. Bakris GL, Agarwal R, Anker SD, Pitt B, et al.
    Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2020;383:2219-2229.

  3. Negro F.
    Residual risk of liver disease after hepatitis C virus eradication.
    J Hepatol. 2020 Dec 1. pii: S0168-8278(20)33827.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016